Pulmonary Emphysema: Clinical Trials

2 trials for Pulmonary Emphysema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 31Unknown 1

Follow Pulmonary Emphysema: new trials by email Literature Review of Pulmonary Emphysema trials Research Report on Pulmonary Emphysema

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Allogeneic MSC Treatment for Pulmonary Emphysema
Allogeneic MSC, Placebo - Pulmonary Emphysema, Mesenchymal Stromal Cells
Phase 2UnknownLeiden University Medical Center302019-06-252021-06-09
Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case Study
IBV Implantation - Pulmonary Emphysema
Phase 2 / Phase 3UnknownHeidelberg University202009-09-012011-04-27

Narrower conditions

Emphysema (1)  ·  Inflammation (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Heidelberg University (1)  ·  Leiden University Medical Center (1)

Countries

Germany (1)  ·  Netherlands (1)

Top investigators

Felix JF Herth, MD (1)

Results publications

PMID 22459779, PMID 38536165